1. Department of Health and Human Services FDA. 21 CFR Part 900 mammography facilities—requirements for accrediting bodies and quality standards and certification requirements: interim rules. Fed Reg. 1993;58:67557–72.
2. Feldman W. How serious are the adverse effects of screening? J Gen Intern Med. 1990;5(suppl):S50–3.
3. Joensuu H, Asola R, Holli K, Kumulainen E, Nikkanen V, Parvinen LM. Delayed diagnosis and large size of breast cancer after a false negative mammogram. Eur J Cancer. 1994;30A(9):1299–302.
4. Johnson M, Hislop T, Kan L, Coldman A, Lai A. Compliance with the screening mammography program of British Columbia: will she return? Can J Public Health. 1996;87(3):176–80.
5. Lerman C, Ross E, Boyce A, et al. Impact of mailing psychoeducational materials to women with abnormal mammograms. Am J Public Health. 1992;82:729–30.